Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Apr 27, 2010

Premium

Patrick Hurban has joined Expression Analysis as vice president of research and development, and Louise Grant as director of operations.

Hurban will be in charge of developing new applications and technologies for the company. He holds a PhD in human genetics from the University of Utah School of Medicine.

Grant will manage and expand Expression Analysis' laboratory. Most recently, she was microbiology program director at BioMérieux. Previously, she worked in R&D, technical support, and product management at Becton Dickinson.


Ardy Arianpour has been promoted to vice president of business development at Ambry Genetics, from director of business development. He joined the company last year and started its pharmaceutical and genomic services division. Previously, he was manager of business development at Cogenics, a division of Clinical Data. He holds an MBA in strategic management from the Marshall Goldsmith School of Management at Alliant International University/University of California, San Diego, and a BS in biological sciences from the University of California, Irvine.


Katherine Richardson has joined Transgenomic as technical director for laboratory services, where she will be responsible for managing the day-to-day operations of the company's services labs. She comes to Transgenomic from OSI Pharmaceuticals, where she did research in molecular biology and development in the area of oncology. She holds a PhD in molecular cellular developmental biology from Iowa State University and a BS in life sciences from the Massachusetts Institute of Technology.


Stéphane Bancel, CEO of BioMérieux, will join the board of directors of Knome, following BioMérieux's recent $5 million equity investment in the company (see related story, this issue).


Daniel Kastner has been elected as a member of the National Academy of Sciences. He is chief of the genetics and genomics branch and clinical director and director of translational research in the intramural research program at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.